(2024)
Real-world treatment patterns according to clinical practice guidelines in patients with type 2 diabetes mellitus and established cardiovascular disease in Korea: Multicenter, retrospective, observational study.
DIABETES & METABOLISM JOURNAL.
-,
-
(2024)
Bipolar disorder and the risk of cardiometabolic diseases, heart failure, and all-cause mortality: a population-based matched cohort study in South Korea.
SCIENTIFIC REPORTS.
14,
1
(2024)
A Multicenter, Randomized, Open-Label Study to Compare the Effects of Gemigliptin Add-on or Escalation of Metformin Dose on Glycemic Control and Safety in Patients with Inadequately Controlled Type 2 Diabetes Mellitus Treated with Metformin and SGLT-2 Inhibitors (SO GOOD Study).
JOURNAL OF DIABETES RESEARCH.
-,
-
(2024)
Psychotic Disorders and the Risk of Type 2 Diabetes, Atherosclerotic Cardiovascular Diseases, and All-Cause Mortality: A Population-Based Matched Cohort Study.
DIABETES & METABOLISM JOURNAL.
-,
-
(2024)
Association between total cholesterol levels and all-cause mortality among newly diagnosed patients with cancer.
SCIENTIFIC REPORTS.
14,
1
(2023)
Increased risk of incident mental disorders in adults with new-onset type 1 diabetes diagnosed after the age of 19: a nationwide cohort study.
DIABETES & METABOLISM.
50,
1
(2023)
Depression, antidepressant use, and the risk of type 2 diabetes: a nationally representative cohort study.
FRONTIERS IN PSYCHIATRY.
14,
(2023)
Association between lipid variability and the risk of mortality in cancer patients not receiving lipid-lowering agents.
FRONTIERS IN ONCOLOGY.
13,
(2023)
2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association.
DIABETES & METABOLISM JOURNAL.
47,
5
(2023)
Low Household Income Status and Death from Pneumonia in People with Type 2 Diabetes Mellitus: A Nationwide Study.
DIABETES & METABOLISM JOURNAL.
47,
5
(2023)
Obesity Is Associated With Higher Risk of Adverse Maternal and Neonatal Outcomes Than Supervised Gestational Diabetes.
JOURNAL OF KOREAN MEDICAL SCIENCE.
38,
33
(2023)
Increased risk of incident diabetes in patients with MAFLD not meeting the criteria for NAFLD.
SCIENTIFIC REPORTS.
13,
1
(2023)
Impact of Continuous Glucose Monitoring on Glycemic Control and Its Derived Metrics in Type 1 Diabetes: A Longitudinal Study.
FRONTIERS IN ENDOCRINOLOGY.
14,
-
(2023)
Association of body weight change with all-cause and cause-specific mortality: A nationwide population-based study.
DIABETES RESEARCH AND CLINICAL PRACTICE.
199,
(2023)
Prognostic significance of albuminuria in elderly of various ages with diabetes.
SCIENTIFIC REPORTS.
13,
1
(2023)
Impaired TFEB activation and mitophagy as a cause of PPP3/calcineurin inhibitor-induced pancreatic beta-cell dysfunction.
AUTOPHAGY.
19,
5
(2023)
Lysosomal Ca2+ as a mediator of palmitate-induced lipotoxicity.
CELL DEATH DISCOVERY.
9,
1
(2023)
MAFLD and NAFLD in the prediction of incident chronic kidney disease.
SCIENTIFIC REPORTS.
13,
1
(2022)
The FimAsartaN proTeinuriA SusTaIned reduCtion in comparison with losartan in diabetic chronic kidney disease (FANTASTIC) trial.
HYPERTENSION RESEARCH.
45,
12
(2022)
Mean and Variability of Lipid Measurements and Risk for Development of Subclinical Left Ventricular Diastolic Dysfunction.
DIABETES & METABOLISM JOURNAL.
46,
2
단행본
(2023)
당뇨병학(6판).
범문에듀케이션.
공동
(2019)
쿠싱증후군의 진단 및 치료.
군자출판사(주).
공동
(2018)
당뇨병학(제5판).
범문에듀케이션.
공동
(2017)
HARRISON'S 내과학.
도서출판 MIP.
공동
학술회의논문
(2020)
Diagnostic Challenge in Cushing Syndrome.
AOCE-SICEM 2020.
대한민국
(2020)
SGLT2i in Primary CVD Prevention.
The 64th Annual Scientific Meeting of The Korean Society of Cardiology.
대한민국
(2019)
DPP-4 inhibitor and gut microbiota in diabetes and obesity.
IDF Congress 2019.
대한민국
(2019)
장내 미생물과 만성대사질환.
제4회 장바이오학회 추계 심포지엄.
대한민국
(2019)
장내 미생물과 만성 대사질환.
2019년 대한내과학회 제70차 추계학술대회.
대한민국
(2019)
Metformin Treatment in Patients with Diabetes and Renal Impairment.
International Congress of Diabetes and Metabolism 2019.
대한민국
(2019)
Inflammation status is independent risk factor for the development of metabolic syndrome in both metabolically healthy obese and nonobese adults.
2019 ADA Scientific Sessions.
미국
(2019)
Microbial Endocrinology.
제32차 대한당뇨병학회 춘계학술대회.
대한민국
(2019)
장내 미생물총(Gut microbiota)과 비만.
2019년 대한비만학회 제38회 춘계연수강좌.
대한민국
(2018)
Role of ROCK1 in Pancreatic beta-cells.
78th ADA Scientific Sessions.
미국
(2018)
경구약제를 이용한 혈당 관리.
대한당뇨병학회 서울 EGDM.
대한민국
(2018)
뇌하수체 질환, 언제 의심할까?.
대한내분비학회 제48회 연수강좌.
대한민국
(2018)
비만과 장내세균 불균형.
2018년 대한소화기학회 춘계학술대회.
대한민국
(2018)
당뇨병 예방과 장내세균총.
2018 당뇨병 예방연구 사업단 심포지엄.
대한민국
(2018)
Target of blood pressure in diabetes.
2018년 대한심뇌혈관질환예방학회 춘계학술대회.
대한민국
(2017)
Role of gut in energy metabolism.
The 16th Postgraduate course of diabetes.
대한민국
(2016)
Medical Treatment of Cushing's Disease.
KNSG 5th Annual Meeting with PEMA & INF.
대한민국
(2016)
Clinical perspectives of gut microbiota.
2016 대한골대사학회 제9차 연구 추계 워크샵.
대한민국
(2016)
Obesogenic diet-induced gut barrier dysfunction and pathobiont expansion cause metabolic syndrome and inflammatory bowel disease.
2016 International Conference on Diabetes and Metabolism.
대한민국
(2016)
Diet-induced Intestinal Changes and Metabolic Disorders.
The 5th International Congress on Lipid Metabolism & Atherosclerosis.
대한민국
